WEST PHARMACEUTICAL SVSC ($WST) posted quarterly earnings results on Thursday, October 23rd. The company reported earnings of $1.96 per share, beating estimates of $1.70 by $0.26. The company also reported revenue of $804,600,000, beating estimates of $795,808,290 by $8,791,710.
You can see Quiver Quantitative's $WST stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
WEST PHARMACEUTICAL SVSC Hedge Fund Activity
We have seen 361 institutional investors add shares of WEST PHARMACEUTICAL SVSC stock to their portfolio, and 338 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GENERATION INVESTMENT MANAGEMENT LLP added 1,165,777 shares (+inf%) to their portfolio in Q2 2025, for an estimated $255,072,007
- FMR LLC removed 634,165 shares (-85.8%) from their portfolio in Q2 2025, for an estimated $138,755,302
- DURABLE CAPITAL PARTNERS LP removed 532,471 shares (-33.8%) from their portfolio in Q2 2025, for an estimated $116,504,654
- FRANKLIN RESOURCES INC removed 456,462 shares (-29.2%) from their portfolio in Q2 2025, for an estimated $99,873,885
- JPMORGAN CHASE & CO removed 435,132 shares (-66.4%) from their portfolio in Q2 2025, for an estimated $95,206,881
- CAPITAL RESEARCH GLOBAL INVESTORS removed 390,678 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $85,480,346
- BLACKROCK, INC. removed 325,197 shares (-4.7%) from their portfolio in Q2 2025, for an estimated $71,153,103
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WEST PHARMACEUTICAL SVSC Congressional Stock Trading
Members of Congress have traded $WST stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $WST stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 07/22.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
WEST PHARMACEUTICAL SVSC Analyst Ratings
Wall Street analysts have issued reports on $WST in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Rothschild & Co issued a "Buy" rating on 09/15/2025
- Evercore ISI Group issued a "Outperform" rating on 07/25/2025
- UBS issued a "Buy" rating on 07/25/2025
To track analyst ratings and price targets for WEST PHARMACEUTICAL SVSC, check out Quiver Quantitative's $WST forecast page.
WEST PHARMACEUTICAL SVSC Price Targets
Multiple analysts have issued price targets for $WST recently. We have seen 4 analysts offer price targets for $WST in the last 6 months, with a median target of $315.5.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $275.0 on 10/02/2025
- Jamie Clark from Rothschild & Co set a target price of $311.0 on 09/15/2025
- Daniel Markowitz from Evercore ISI Group set a target price of $350.0 on 07/25/2025
- John Sourbeer from UBS set a target price of $320.0 on 07/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
